⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADCT News
ADC Therapeutics SA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
prnewswire.com
ADCT
Bronstein, Gewirtz & Grossman, LLC Is Investigating ADC Therapeutics SA (ADCT) And Encourages Stockholders to Connect
accessnewswire.com
ADCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
globenewswire.com
ADCT
ADC Therapeutics SA (ADCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ADCT
Form 8-K
sec.gov
ADCT
Post-ASCO 2026 Insights: Trial Development and Execution Strategies, Upcoming Webinar Hosted by Xtalks
prnewswire.com
ADCT
Form 8-K
sec.gov
ADCT
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
prnewswire.com
ADCT
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire.com
ADCT
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL